Statement of Changes in Beneficial Ownership (4)
October 05 2015 - 5:42PM
Edgar (US Regulatory)
FORM 4
[
X
]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
EMERSON MARTIN J
|
2. Issuer Name
and
Ticker or Trading Symbol
WRIGHT MEDICAL GROUP INC
[
WMGI
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__
X
__ Director
_____ 10% Owner
_____ Officer (give title below)
_____ Other (specify below)
|
(Last)
(First)
(Middle)
4659 FABLE HILL WAY N.
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
10/1/2015
|
(Street)
HUGO, MN 55038
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
10/1/2015
|
|
D
|
|
28280
|
D
|
(1)
|
0
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Outside Director Stock Option (Right to Buy)
|
$19.89
|
10/1/2015
|
|
D
|
|
|
20000
|
(2)
|
4/13/2016
|
Common Stock
|
20000
|
(3)
|
0
|
D
|
|
Outside Director Stock Option (Right to Buy)
|
$24.08
|
10/1/2015
|
|
D
|
|
|
12500
|
(2)
|
5/17/2017
|
Common Stock
|
12500
|
(4)
|
0
|
D
|
|
Outside Director Stock Option (Right to Buy)
|
$29.19
|
10/1/2015
|
|
D
|
|
|
10000
|
(2)
|
5/14/2018
|
Common Stock
|
10000
|
(5)
|
0
|
D
|
|
Outside Director Stock Option (Right to Buy)
|
$15.47
|
10/1/2015
|
|
D
|
|
|
10000
|
(2)
|
5/13/2019
|
Common Stock
|
10000
|
(6)
|
0
|
D
|
|
Outside Director Stock Option (Right to Buy)
|
$18.37
|
10/1/2015
|
|
D
|
|
|
10000
|
(2)
|
5/13/2020
|
Common Stock
|
10000
|
(7)
|
0
|
D
|
|
Outside Director Stock Option (Right to Buy)
|
$15.50
|
10/1/2015
|
|
D
|
|
|
10000
|
(2)
|
5/11/2021
|
Common Stock
|
10000
|
(8)
|
0
|
D
|
|
Outside Director Stock Option (Right to Buy)
|
$21.39
|
10/1/2015
|
|
D
|
|
|
10000
|
(2)
|
5/9/2022
|
Common Stock
|
10000
|
(9)
|
0
|
D
|
|
Outside Director Stock Option (Right to Buy)
|
$24.66
|
10/1/2015
|
|
D
|
|
|
10000
|
(2)
|
5/14/2023
|
Common Stock
|
10000
|
(10)
|
0
|
D
|
|
Outside Director Stock Option (Right to Buy)
|
$29.95
|
10/1/2015
|
|
D
|
|
|
10000
|
(2)
|
5/13/2024
|
Common Stock
|
10000
|
(11)
|
0
|
D
|
|
Explanation of Responses:
|
(
1)
|
Disposed of pursuant to the Agreement and Plan of Merger by and among the issuer, Tornier N.V., Trooper Holdings Inc., and Trooper Merger Sub Inc., which became effective on October 1, 2015, in exchange for 29,153 Wright Medical Group N.V. ("Wright N.V.") ordinary shares having a market value of $20.39 per share at the effective time of the merger.
|
(
2)
|
The outside director stock option vests in equal annual installments over a period of four years after the grant date.
|
(
3)
|
This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 20,618 Wright N.V. at a price of $19.30 per share.
|
(
4)
|
This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 12,886 Wright N.V. at a price of $23.36 per share.
|
(
5)
|
This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,309 Wright N.V. at a price of $28.32 per share.
|
(
6)
|
This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,309 Wright N.V. at a price of $15.01 per share.
|
(
7)
|
This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,309 Wright N.V. at a price of $17.82 per share.
|
(
8)
|
This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,309 Wright N.V. at a price of $15.04 per share.
|
(
9)
|
This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,309 Wright N.V. at a price of $20.75 per share.
|
(
10)
|
This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,309 Wright N.V. at a price of $23.93 per share.
|
(
11)
|
This option was assumed by Wright N.V. in the merger and replaced with an option to purchase 10,309 Wright N.V. at a price of $29.06 per share.
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
EMERSON MARTIN J
4659 FABLE HILL WAY N.
HUGO, MN 55038
|
X
|
|
|
|
Signatures
|
/s/ Marija S. Nelson, Attorney-in-fact
|
|
10/5/2015
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
Wright Medical Group NV (NASDAQ:WMGI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Wright Medical Group NV (NASDAQ:WMGI)
Historical Stock Chart
From Sep 2023 to Sep 2024